Conversely, other patients’ demographical and clinical features such as younger age, lower BMI, and higher daily insulin dose, which have been demonstrated as factors associated to increased lipodystrophy risk in other studies [22,26,35,36], did not influence the occurrence of lipodystrophy in our study population. The gene discussed is INS; the disease is lipodystrophy.